Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Buy
260,892
+187,341
+255% +$21.9M 0.4% 60
2026
Q1
$8.84M Buy
73,551
+26,631
+57% +$3.07M 0.12% 121
2025
Q4
$4.93M Sell
46,920
-3,076
-6% -$289K 0.07% 176
2025
Q3
$4.14M Buy
49,996
+3,535
+8% +$291K 0.06% 184
2025
Q2
$3.66M Sell
46,461
-23,943
-34% -$1.9M 0.06% 175
2025
Q1
$6.16M Sell
70,404
-119,337
-63% -$11.1M 0.13% 108
2024
Q4
$18.8M Buy
+189,741
New +$19.6M 0.46% 45

Other funds holding MRK

Groupe la Francaise's MRK Position: Q2 2026 in Review

Groupe la Francaise increased its Merck (MRK) stake by 255% in Q2 2026, buying an estimated $21.9M and bringing the position to 260,892 shares worth $33.5M. The position accounts for 0.4% of the portfolio, ranked #60.

Groupe la Francaise first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Groupe la Francaise held 260,892 shares of Merck worth $33.5M as of Q2 2026.
  • Groupe la Francaise bought 187,341 Merck shares in Q2 2026, an estimated $21.9M.
  • Merck made up 0.4% of Groupe la Francaise's portfolio in Q2 2026, its #60 holding.
  • Groupe la Francaise first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.